Global Patient-derived Xenograft (PDX) Models Market Growth (Status and Outlook) 2022-2028
- LP 4955092
- 114 Pages
- May 2022
- Medical Devices
The United States Patient-derived Xenograft (PDX) Models market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Patient-derived Xenograft (PDX) Models market, reaching US$ million by the year 2028. As for the Europe Patient-derived Xenograft (PDX) Models landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Patient-derived Xenograft (PDX) Models players cover Crown Bioscience, Champions Oncology, Wuxi Apptec, and The Jackson Laboratory, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient-derived Xenograft (PDX) Models market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Mouse Model
Rat Model
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Preclinical Drug development
Biomarker Analysis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Patient-derived Xenograft (PDX) Models Market Size 2017-2028
2.1.2 Patient-derived Xenograft (PDX) Models Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Patient-derived Xenograft (PDX) Models Segment by Type
2.2.1 Mouse Model
2.2.2 Rat Model
2.3 Patient-derived Xenograft (PDX) Models Market Size by Type
2.3.1 Patient-derived Xenograft (PDX) Models Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
2.4 Patient-derived Xenograft (PDX) Models Segment by Application
2.4.1 Preclinical Drug development
2.4.2 Biomarker Analysis
2.5 Patient-derived Xenograft (PDX) Models Market Size by Application
2.5.1 Patient-derived Xenograft (PDX) Models Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
3 Patient-derived Xenograft (PDX) Models Market Size by Player
3.1 Patient-derived Xenograft (PDX) Models Market Size Market Share by Players
3.1.1 Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2022)
3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2020-2022)
3.2 Global Patient-derived Xenograft (PDX) Models Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Patient-derived Xenograft (PDX) Models by Regions
4.1 Patient-derived Xenograft (PDX) Models Market Size by Regions (2017-2022)
4.2 Americas Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
4.3 APAC Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
4.4 Europe Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
4.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Growth (2017-2022)
5 Americas
5.1 Americas Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022)
5.2 Americas Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
5.3 Americas Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022)
6.2 APAC Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
6.3 APAC Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Patient-derived Xenograft (PDX) Models by Country (2017-2022)
7.2 Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Patient-derived Xenograft (PDX) Models by Region (2017-2022)
8.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022)
8.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Patient-derived Xenograft (PDX) Models Market Forecast
10.1 Global Patient-derived Xenograft (PDX) Models Forecast by Regions (2023-2028)
10.1.1 Global Patient-derived Xenograft (PDX) Models Forecast by Regions (2023-2028)
10.1.2 Americas Patient-derived Xenograft (PDX) Models Forecast
10.1.3 APAC Patient-derived Xenograft (PDX) Models Forecast
10.1.4 Europe Patient-derived Xenograft (PDX) Models Forecast
10.1.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Forecast
10.2 Americas Patient-derived Xenograft (PDX) Models Forecast by Country (2023-2028)
10.2.1 United States Patient-derived Xenograft (PDX) Models Market Forecast
10.2.2 Canada Patient-derived Xenograft (PDX) Models Market Forecast
10.2.3 Mexico Patient-derived Xenograft (PDX) Models Market Forecast
10.2.4 Brazil Patient-derived Xenograft (PDX) Models Market Forecast
10.3 APAC Patient-derived Xenograft (PDX) Models Forecast by Region (2023-2028)
10.3.1 China Patient-derived Xenograft (PDX) Models Market Forecast
10.3.2 Japan Patient-derived Xenograft (PDX) Models Market Forecast
10.3.3 Korea Patient-derived Xenograft (PDX) Models Market Forecast
10.3.4 Southeast Asia Patient-derived Xenograft (PDX) Models Market Forecast
10.3.5 India Patient-derived Xenograft (PDX) Models Market Forecast
10.3.6 Australia Patient-derived Xenograft (PDX) Models Market Forecast
10.4 Europe Patient-derived Xenograft (PDX) Models Forecast by Country (2023-2028)
10.4.1 Germany Patient-derived Xenograft (PDX) Models Market Forecast
10.4.2 France Patient-derived Xenograft (PDX) Models Market Forecast
10.4.3 UK Patient-derived Xenograft (PDX) Models Market Forecast
10.4.4 Italy Patient-derived Xenograft (PDX) Models Market Forecast
10.4.5 Russia Patient-derived Xenograft (PDX) Models Market Forecast
10.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Forecast by Region (2023-2028)
10.5.1 Egypt Patient-derived Xenograft (PDX) Models Market Forecast
10.5.2 South Africa Patient-derived Xenograft (PDX) Models Market Forecast
10.5.3 Israel Patient-derived Xenograft (PDX) Models Market Forecast
10.5.4 Turkey Patient-derived Xenograft (PDX) Models Market Forecast
10.5.5 GCC Countries Patient-derived Xenograft (PDX) Models Market Forecast
10.6 Global Patient-derived Xenograft (PDX) Models Forecast by Type (2023-2028)
10.7 Global Patient-derived Xenograft (PDX) Models Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Offered
11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Champions Oncology
11.2.1 Champions Oncology Company Information
11.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Offered
11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Champions Oncology Main Business Overview
11.2.5 Champions Oncology Latest Developments
11.3 Wuxi Apptec
11.3.1 Wuxi Apptec Company Information
11.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Offered
11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Wuxi Apptec Main Business Overview
11.3.5 Wuxi Apptec Latest Developments
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Information
11.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Offered
11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 The Jackson Laboratory Main Business Overview
11.4.5 The Jackson Laboratory Latest Developments
11.5 EPO Berlin-Buch
11.5.1 EPO Berlin-Buch Company Information
11.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Offered
11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 EPO Berlin-Buch Main Business Overview
11.5.5 EPO Berlin-Buch Latest Developments
11.6 Oncodesign
11.6.1 Oncodesign Company Information
11.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Offered
11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Oncodesign Main Business Overview
11.6.5 Oncodesign Latest Developments
11.7 Xentech
11.7.1 Xentech Company Information
11.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Offered
11.7.3 Xentech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Xentech Main Business Overview
11.7.5 Xentech Latest Developments
11.8 Envigo
11.8.1 Envigo Company Information
11.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Offered
11.8.3 Envigo Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Envigo Main Business Overview
11.8.5 Envigo Latest Developments
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Information
11.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Offered
11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Charles River Laboratories Main Business Overview
11.9.5 Charles River Laboratories Latest Developments
11.10 Pharmatest Services
11.10.1 Pharmatest Services Company Information
11.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Offered
11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pharmatest Services Main Business Overview
11.10.5 Pharmatest Services Latest Developments
11.11 Urosphere
11.11.1 Urosphere Company Information
11.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Offered
11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Urosphere Main Business Overview
11.11.5 Urosphere Latest Developments
11.12 MEDICILON
11.12.1 MEDICILON Company Information
11.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Offered
11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 MEDICILON Main Business Overview
11.12.5 MEDICILON Latest Developments
11.13 Horizon Discovery
11.13.1 Horizon Discovery Company Information
11.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Offered
11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Horizon Discovery Main Business Overview
11.13.5 Horizon Discovery Latest Developments
11.14 Shanghai Model Organisms Center
11.14.1 Shanghai Model Organisms Center Company Information
11.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Offered
11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Shanghai Model Organisms Center Main Business Overview
11.14.5 Shanghai Model Organisms Center Latest Developments
11.15 GemPharmatech
11.15.1 GemPharmatech Company Information
11.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Offered
11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 GemPharmatech Main Business Overview
11.15.5 GemPharmatech Latest Developments
11.16 LIDE Biotech
11.16.1 LIDE Biotech Company Information
11.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Offered
11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 LIDE Biotech Main Business Overview
11.16.5 LIDE Biotech Latest Developments
12 Research Findings and Conclusion
Table 1. Patient-derived Xenograft (PDX) Models Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Mouse Model
Table 3. Major Players of Rat Model
Table 4. Patient-derived Xenograft (PDX) Models Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
Table 7. Patient-derived Xenograft (PDX) Models Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
Table 10. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Player (2020-2022)
Table 12. Patient-derived Xenograft (PDX) Models Key Players Head office and Products Offered
Table 13. Patient-derived Xenograft (PDX) Models Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Patient-derived Xenograft (PDX) Models Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Regions (2017-2022)
Table 18. Americas Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Country (2017-2022)
Table 20. Americas Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
Table 22. Americas Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
Table 24. APAC Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Region (2017-2022)
Table 26. APAC Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
Table 28. APAC Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
Table 30. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Country (2017-2022)
Table 32. Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Patient-derived Xenograft (PDX) Models
Table 43. Key Market Challenges & Risks of Patient-derived Xenograft (PDX) Models
Table 44. Key Industry Trends of Patient-derived Xenograft (PDX) Models
Table 45. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Patient-derived Xenograft (PDX) Models Market Size Market Share Forecast by Application (2023-2028)
Table 51. Crown Bioscience Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 52. Crown Bioscience Patient-derived Xenograft (PDX) Models Product Offered
Table 53. Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Crown Bioscience Main Business
Table 55. Crown Bioscience Latest Developments
Table 56. Champions Oncology Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 57. Champions Oncology Patient-derived Xenograft (PDX) Models Product Offered
Table 58. Champions Oncology Main Business
Table 59. Champions Oncology Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Champions Oncology Latest Developments
Table 61. Wuxi Apptec Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 62. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Offered
Table 63. Wuxi Apptec Main Business
Table 64. Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Wuxi Apptec Latest Developments
Table 66. The Jackson Laboratory Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 67. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Offered
Table 68. The Jackson Laboratory Main Business
Table 69. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. The Jackson Laboratory Latest Developments
Table 71. EPO Berlin-Buch Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 72. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Offered
Table 73. EPO Berlin-Buch Main Business
Table 74. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. EPO Berlin-Buch Latest Developments
Table 76. Oncodesign Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 77. Oncodesign Patient-derived Xenograft (PDX) Models Product Offered
Table 78. Oncodesign Main Business
Table 79. Oncodesign Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Oncodesign Latest Developments
Table 81. Xentech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 82. Xentech Patient-derived Xenograft (PDX) Models Product Offered
Table 83. Xentech Main Business
Table 84. Xentech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Xentech Latest Developments
Table 86. Envigo Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 87. Envigo Patient-derived Xenograft (PDX) Models Product Offered
Table 88. Envigo Main Business
Table 89. Envigo Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Envigo Latest Developments
Table 91. Charles River Laboratories Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 92. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Offered
Table 93. Charles River Laboratories Main Business
Table 94. Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Charles River Laboratories Latest Developments
Table 96. Pharmatest Services Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 97. Pharmatest Services Patient-derived Xenograft (PDX) Models Product Offered
Table 98. Pharmatest Services Main Business
Table 99. Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Pharmatest Services Latest Developments
Table 101. Urosphere Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 102. Urosphere Patient-derived Xenograft (PDX) Models Product Offered
Table 103. Urosphere Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Urosphere Main Business
Table 105. Urosphere Latest Developments
Table 106. MEDICILON Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 107. MEDICILON Patient-derived Xenograft (PDX) Models Product Offered
Table 108. MEDICILON Main Business
Table 109. MEDICILON Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. MEDICILON Latest Developments
Table 111. Horizon Discovery Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 112. Horizon Discovery Patient-derived Xenograft (PDX) Models Product Offered
Table 113. Horizon Discovery Main Business
Table 114. Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Horizon Discovery Latest Developments
Table 116. Shanghai Model Organisms Center Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 117. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Offered
Table 118. Shanghai Model Organisms Center Main Business
Table 119. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Shanghai Model Organisms Center Latest Developments
Table 121. GemPharmatech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 122. GemPharmatech Patient-derived Xenograft (PDX) Models Product Offered
Table 123. GemPharmatech Main Business
Table 124. GemPharmatech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. GemPharmatech Latest Developments
Table 126. LIDE Biotech Details, Company Type, Patient-derived Xenograft (PDX) Models Area Served and Its Competitors
Table 127. LIDE Biotech Patient-derived Xenograft (PDX) Models Product Offered
Table 128. LIDE Biotech Main Business
Table 129. LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. LIDE Biotech Latest Developments
List of Figures
Figure 1. Patient-derived Xenograft (PDX) Models Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
Figure 7. Patient-derived Xenograft (PDX) Models in Preclinical Drug development
Figure 8. Global Patient-derived Xenograft (PDX) Models Market: Preclinical Drug development (2017-2022) & ($ Millions)
Figure 9. Patient-derived Xenograft (PDX) Models in Biomarker Analysis
Figure 10. Global Patient-derived Xenograft (PDX) Models Market: Biomarker Analysis (2017-2022) & ($ Millions)
Figure 11. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
Figure 12. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Player in 2021
Figure 13. Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
Figure 15. APAC Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
Figure 16. Europe Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size 2017-2022 ($ Millions)
Figure 18. Americas Patient-derived Xenograft (PDX) Models Value Market Share by Country in 2021
Figure 19. Americas Patient-derived Xenograft (PDX) Models Consumption Market Share by Type in 2021
Figure 20. Americas Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
Figure 21. United States Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Region in 2021
Figure 26. APAC Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
Figure 27. China Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Country in 2021
Figure 34. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
Figure 35. Europe Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
Figure 36. Germany Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Market Share by Application in 2021
Figure 44. Egypt Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Patient-derived Xenograft (PDX) Models Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 50. APAC Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 51. Europe Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 53. United States Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 54. Canada Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 57. China Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 58. Japan Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 59. Korea Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 61. India Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 62. Australia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 63. Germany Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 64. France Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 65. UK Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 66. Italy Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 67. Russia Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 68. Spain Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 71. Israel Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Patient-derived Xenograft (PDX) Models Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
